NCT03826043 2025-09-30
THEO
Centre Antoine Lacassagne
Phase NA Completed
Clinical Trials
12 trialsNCT05293041 2025-03-06
ARG-01
Sahlgrenska University Hospital
Phase 4 Completed
NCT03692065 2025-02-06
API-CAT
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT05507645 2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3 Completed
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT04324346 2021-03-18
PICC&PAC
Swedish Red Cross University College
Phase NA Completed
NCT02285738 2019-05-08
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT02548377 2018-03-05
RIPC-HNC
Aarhus University Hospital Skejby
Phase NA Completed
NCT00216866 2017-08-28
The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Completed
NCT00320255 2016-08-16
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
Bristol-Myers Squibb
Phase 2 Completed
NCT02724475 2016-03-31
Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT01853202 2014-12-04
EXPECT
University of Vermont
Phase NA Completed